Stay updated on Geptanolimab+Fruquintinib in Metastatic Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Geptanolimab+Fruquintinib in Metastatic Colorectal Cancer Clinical Trial page.

Latest updates to the Geptanolimab+Fruquintinib in Metastatic Colorectal Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe page shows a revision tag updated from v3.5.3 to v3.5.4, indicating a backend/template update. This change does not modify study content or enrollment information.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedClinicalTrials.gov’s page footer/version indicator was updated from Revision v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check29 days agoChange DetectedRevision history updated: added v3.5.2 and removed v3.5.0.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.1%

- Check65 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check94 days agoChange DetectedRevision: v3.4.2 was added and the prior government funding notice was removed. This update does not affect the study details or data presented on the page.SummaryDifference0.4%

Stay in the know with updates to Geptanolimab+Fruquintinib in Metastatic Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Geptanolimab+Fruquintinib in Metastatic Colorectal Cancer Clinical Trial page.